Fully Allocated Financing at Premium Signals Strategic Investor Demand in Silver Royalty Space
Source: Streetwise Reports 04/13/2026
Silver Crown Royalties Inc. (SCRI:CBOE; SLCRF:OTCQX; QS0:FSE) announced a CA$4.5 million private placement priced at a 5% premium to market.
Silver Crown Royalties Inc. (SCRI:CBOE; SLCRF:OTCQX; QS0:FSE) announced that it has arranged a fully allocated non-brokered private placement of common shares for gross proceeds of approximately CA$4.5 million. The offering consists of 321,429 common shares issued to strategic investors at a price of CA$14 per share. The company stated that the offering price represents a 5% premium to the closing price of the common shares on the Cboe Canada Exchange on April 10, 2026.
The company indicated that the offering is expected to close on or about April 17, subject to customary closing conditions, including all necessary regulatory approvals. Common shares issued under the offering will be subject to a statutory hold period of four months and one day from the date of issuance. The company also stated that no finders’ fees or other consideration will be payable in connection with the offering.
Peter Bures, president and chief executive officer of the corporation, stated, “We are excited to announce this fully allocated, minimally dilutive equity financing at a premium to market. The proceeds will fully finance our pipeline of growth opportunities to our unaffected share price.” He added that, “When combined with our nearly CA$10-million cash in hand, the proceeds will fully finance our pipeline of growth opportunities.”
Silver Holds Key Levels as Volatility Drives Market Action
According to an April 12 update from Excelsior Prosperity with Shad Marquitz, silver pricing had remained within a wide range, with the metal closing the prior week at US$76.48 after recovering from a decline to US$61.21 on March 23. The report noted that this marked “a 3rd week in a row of green candles, in this relief rally in the silver price,” and added that the move occurred while holding above the 50-week Exponential Moving Average support level of US$58.71. The same update highlighted earlier volatility, stating that silver had reached “the all-time intra-week high on January 29 at US$121.78″ before reversing to US$63.90 the following week. It also stated that “the overall larger trend is still bullish, and the March correction has not invalidated that trend,” while noting that silver would need to hold above US$61.21 on a daily and weekly basis.
Catherine Brock wrote on April 13 that silver futures opened at US$73.69 per ounce, down 3.6% from the previous close of US$76.48, before rising to US$74.47 in early trading. The report stated that the latest CPI data showed March prices increased 3.3%, the largest gain since April 2024, with higher gas prices related to the Iran war identified as the primary contributor. It added that “absent other factors, higher interest rates typically reduce gold demand and pricing,” while also noting that escalating geopolitical tensions contributed to market uncertainty.
In a separate April 13 analysis, Muhammad Umair wrote that “gold and silver faced initial pressure as rising geopolitical tensions and a surge in oil prices triggered volatility and risk-off sentiment.” The report stated that silver had rebounded from a support zone near US$60 and was consolidating above the US$72 level, adding that “as long as silver remains above US$60, the structure still suggests an upward move.” It also noted that industrial demand factors influenced silver, stating that “silver demand will be determined by the strength of industrial demand as costs increase,” while broader market conditions, including inflation and energy prices, contributed to uncertainty in pricing.
Third Party Commentary Highlights Breakout Momentum and Royalty Model Validation
In a January 14 report from John Newell of John Newell & Associates, he reiterated his prior rating on the company as a “Speculative Buy,” stating that “since the original article … was published in late December, the company has moved decisively higher.” He wrote that “what was previously a constructive base has now resolved into a strong upside breakout, validating both the technical setup and the underlying silver royalty thesis.”
Newell also detailed price performance relative to prior targets, stating that the stock “has successfully reached all three previously identified upside targets,” including “first target: CA$7.75 met,” “second target: CA$9.00 met,” and “third target: CA$10.25 met.” He added that “the move has been accompanied by strong volume expansion,” and noted that “price has pushed well above former resistance, which now shifts into a potential support zone.”
He further stated that “with the intermediate targets achieved, focus now shifts to the big picture objective at CA$12.50 [met],” which he described as aligning “with longer-term resistance and valuation expansion implied by improving silver fundamentals and portfolio growth.” In the same report, he also wrote that “the combination of price confirmation and governance enhancement materially improves the overall risk-reward profile.”
According to an April 8 report from Peter Krauth, the company’s financial and operational performance was discussed, with Krauth stating that “Silver Crown delivered a strong and transformative 2025, marked by impressive revenue growth and a rapidly expanding silver royalty portfolio.” He added that the company reported “record revenue of CA$1.23 million, driven by higher minimum silver deliveries of 22,281 ounces,” noting that this represented “standout growth of 53% year-over-year in deliveries and 112% in revenue.”
Krauth also addressed asset-level developments, stating that the company “expanded its portfolio with key acquisitions,” including a royalty on the Igor 4 Project in Peru and exposure to the Scotia Mine in Nova Scotia. He further noted that “the PGDM Complex in Brazil faced temporary setbacks,” while “the Elk Gold Mine experienced a pause in operations following a change in ownership,” and that “progress at the BacTech bioleaching facility in Ecuador has been slower than expected.”
In the same April 8 report, Peter Bures, CEO, stated, “2025 was a formative year for your company. We structured and acquired multiple royalties (specifically PPX and EDM), positioning us for aggressive revenue growth in 2026.” He added that “with over CA$7 million in cash and silver bullion on our balance sheet, we can add additional royalties without further dilution,” and noted that “our pipeline remains robust and we continue to advance a number of royalty opportunities.”
Operational Milestones and Royalty Portfolio Developments
The company presentation outlined multiple royalty agreements and transaction structures across its portfolio, including staged payments, minimum delivery obligations, and equity-linked components.
At the PPX Mining Corp. (PPX:TSXV; PPX:BVL) Igor 4 project in Peru, the company paid US$2.5 million for 15% of silver produced, capped at 225,000 ounces. The operator has the right to increase the silver ounce commitment to 30% from 15% through an additional payment of US$2.5 million in equity.
At the EDM Resources (EDM:TSXV;SWNLF:OTCMKTS) Scotia Mine in Nova Scotia, the company paid CA$1.0 million for 90% of silver produced, with the payment split equally between cash and equity. The operator may increase annual silver delivery commitments from 7,000 ounces to 10,000 ounces through an additional CA$500,000 equity payment.
At the Pilar Gold PGDM complex in Brazil, the company paid US$2.0 million for 90% of silver produced. The operator retains the option to increase minimum annual silver deliveries from 16,000 ounces to 32,000 ounces through an additional US$1.5 million equity payment.
At the BacTech Environmental (OTCMKTS: BCCEF) Ecuador plant, the company paid CA$1.0 million for 90% of silver produced. Additional payments include CA$1.0 million upon funding and CA$2.0 million upon plant startup, both in equity. [OWNERSHIP_CHART-10873]
At the Gold Mountain Mining Elk Gold project in British Columbia, the company paid CA$2.5 million for 90% of silver produced. The operator has the option to increase minimum delivery payments in 2,000-ounce increments up to 20,000 ounces, with each increment requiring a CA$500,000 equity payment, for a total potential disbursement of CA$6.5 million.
The presentation also stated that the company has averaged two royalties per year and maintains more than 10 active discussions at any given time related to its pipeline of opportunities.
Ownership and Share Structure1
Insiders and management, including their friends and family, hold a total of 21% of the company. Institutions own 12%, and private corporations have 10%, according to the company’s investor presentation.
As for share structure, Silver Crown has approximately 4.47 million outstanding shares. Its market capitalization is roughly CA$69.2 million, and its 52-week trading range is CA$5.27 to CA$24.91 per share.
Sign up for our FREE newsletter at: www.streetwisereports.com/get-news
Important Disclosures:
- Silver Crown Royalties has a consulting relationship with Street Smart an affiliate of Streetwise Reports. Street Smart Clients pay a monthly consulting fee between US$8,000 and US$20,000.
- As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Silver Crown, EDM Resources, and Bactech Environmental Corp.
- James Guttman wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
For additional disclosures, please click here.
1. Ownership and Share Structure Information
The information listed above was updated on the date this article was published and was compiled from information from the company and various other data providers.
( Companies Mentioned: SCRI:CBOE; SLCRF:OTCQX; QS0:FSE, )
Source: https://www.streetwisereports.com/article/2026/04/13/fully-allocated-financing-at-premium-signals-strategic-investor-demand-in-silver-royalty-space.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

